Description
PRINCIPIO ACTIVO: BRIMONIDINA TARTRATO 0
Polvo liofilizado para solución inyectable
CAJA C/7 (CINA)
HEMLIBRA 150 mg/mL | Solución Inyectable | Frasco Ámpula | Roche
Uso exclusivo bajo supervisión médica en entorno hospitalario
METOTREXATO 50 TAB 2.5 MG NAPROXENO 10.00 G LIDOCAINA 2.00 G PRINCIPIO ACTIVO: BRIMONIDINA TARTRATO 0
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
